Literature DB >> 25184858

Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility.

Agnes Schonbrunn1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25184858      PMCID： PMC4154242          DOI： 10.1210/me.2014-1230

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN： 0888-8809


× No keyword cloud information.
  36 in total

Review 1.  A guide to the perplexed on the specificity of antibodies.

Authors:  Clifford B Saper
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

2.  Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Authors:  Serena Bodei; Nicola Arrighi; PierFranco Spano; Sandra Sigala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-19       Impact factor: 3.000

3.  Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors.

Authors:  Wisuit Pradidarcheep; Jan Stallen; Wil T Labruyère; Noshir F Dabhoiwala; Martin C Michel; Wouter H Lamers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-07       Impact factor: 3.000

4.  Commercial antibodies: the good, bad, and really ugly.

Authors:  John R Couchman
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

Review 5.  Hitchhiker antigens: inconsistent ChIP results, questionable immunohistology data, and poor antibody performance may have a common factor.

Authors:  Missag Hagop Parseghian
Journal:  Biochem Cell Biol       Date:  2013-10-23       Impact factor: 3.626

6.  The antibody challenge.

Authors:  Jeffrey M Perkel
Journal:  Biotechniques       Date:  2014-03-01       Impact factor: 1.993

7.  Specificity controls for immunocytochemistry: the antigen preadsorption test can lead to inaccurate assessment of antibody specificity.

Authors:  Silvia Holmseth; Yun Zhou; Virginie V Follin-Arbelet; Knut Petter Lehre; Dwight E Bergles; Niels Christian Danbolt
Journal:  J Histochem Cytochem       Date:  2012-01-03       Impact factor: 2.479

8.  Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.

Authors:  Sharon Pozner-Moulis; Melissa Cregger; Robert L Camp; David L Rimm
Journal:  Lab Invest       Date:  2007-01-29       Impact factor: 5.662

9.  Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein.

Authors:  Marcela Herrera; Matthew A Sparks; Adolfo R Alfonso-Pecchio; Lisa M Harrison-Bernard; Thomas M Coffman
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

10.  Where is TRPV1 expressed in the bladder, do we see the real channel?

Authors:  Wouter Everaerts; M Rosario Sepúlveda; Thomas Gevaert; Tania Roskams; Bernd Nilius; Dirk De Ridder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-20       Impact factor: 3.000
View more
  14 in total

1.  Editorial: Reproducibility in Research: A Cautionary Tale and Lessons Not Learned.

Authors:  Agnes Schonbrunn
Journal:  Mol Endocrinol       Date:  2015-09

2.  Divergence in DNA Specificity among Paralogous Transcription Factors Contributes to Their Differential In Vivo Binding.

Authors:  Ning Shen; Jingkang Zhao; Joshua L Schipper; Yuning Zhang; Tristan Bepler; Dan Leehr; John Bradley; John Horton; Hilmar Lapp; Raluca Gordan
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

3.  A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors.

Authors:  Anand Venkataraman; Kun Yang; Jose Irizarry; Mark Mackiewicz; Paolo Mita; Zheng Kuang; Lin Xue; Devlina Ghosh; Shuang Liu; Pedro Ramos; Shaohui Hu; Diane Bayron Kain; Sarah Keegan; Richard Saul; Simona Colantonio; Hongyan Zhang; Florencia Pauli Behn; Guang Song; Edisa Albino; Lillyann Asencio; Leonardo Ramos; Luvir Lugo; Gloriner Morell; Javier Rivera; Kimberly Ruiz; Ruth Almodovar; Luis Nazario; Keven Murphy; Ivan Vargas; Zully Ann Rivera-Pacheco; Christian Rosa; Moises Vargas; Jessica McDade; Brian S Clark; Sooyeon Yoo; Seva G Khambadkone; Jimmy de Melo; Milanka Stevanovic; Lizhi Jiang; Yana Li; Wendy Y Yap; Brittany Jones; Atul Tandon; Elliot Campbell; Gaetano T Montelione; Stephen Anderson; Richard M Myers; Jef D Boeke; David Fenyö; Gordon Whiteley; Joel S Bader; Ignacio Pino; Daniel J Eichinger; Heng Zhu; Seth Blackshaw
Journal:  Nat Methods       Date:  2018-03-19       Impact factor: 28.547

4.  Estrogen receptor profiling and activity in cardiac myocytes.

Authors:  Emily K Pugach; Christa L Blenck; Joseph M Dragavon; Stephen J Langer; Leslie A Leinwand
Journal:  Mol Cell Endocrinol       Date:  2016-05-07       Impact factor: 4.102

5.  Western Blotting with Solutions containing Nanoliter Volumes of Antibody.

Authors:  David A Cruz Walma; Joshua W Collins
Journal:  Curr Protoc Cell Biol       Date:  2019-09

6.  Although it's painful: The importance of stringent antibody validation.

Authors:  Victoria A Meliopoulos; Stacey Schultz-Cherry
Journal:  PLoS Pathog       Date:  2018-01-04       Impact factor: 6.823

7.  Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies.

Authors:  Valeria Burghi; Natalia Cristina Fernández; Yamila Belén Gándola; Verónica Gabriela Piazza; Diego Tomás Quiroga; Érica Guilhen Mario; Janaína Felix Braga; Michael Bader; Robson Augusto Souza Santos; Fernando Pablo Dominici; Marina Cecilia Muñoz
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Nanoparticle Enhancement Cascade for Sensitive Multiplex Measurements of Biomarkers in Complex Fluids with Surface Plasmon Resonance Imaging.

Authors:  Jan Hendriks; Ivan Stojanovic; Richard B M Schasfoort; Daniël B F Saris; Marcel Karperien
Journal:  Anal Chem       Date:  2018-05-15       Impact factor: 6.986

Review 9.  A ChIP on the shoulder? Chromatin immunoprecipitation and validation strategies for ChIP antibodies.

Authors:  Fiona C Wardle; Haihan Tan
Journal:  F1000Res       Date:  2015-07-13

10.  Evaluation and validation of commercial antibodies for the detection of Shb.

Authors:  Güliz Vanli; Alvaro Cuesta-Marban; Christian Widmann
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.